Sign up now with your company or organization email and enjoy a
1-week free trial!
Contract Details
| Title |
Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for Medicinal Products with the Active Ingredient Peginterferon Beta-1a (atc: L03ab13) As Part of a So-called Open House Model Germany |
|||
|---|---|---|---|---|
You can sign up and unlock it for freeAccess to Public and Private Sector Business Opportunities for 200+ Countries |
||||
| Country | ||||
| Language | English | |||
| Organization | ||||
| Published Date | 06.02.2024 | |||
| Awarded Date | 03.02.2021 | |||
| Overview | Contract Award's Details : Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for Medicinal Products with the Active Ingredient Peginterferon Beta-1a (atc: L03ab13) As Part of a So-called Open House Model AOK - RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE COMPANY Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for Medicinal Products with the Active Ingredient Peginterferon Beta-1a (atc: L03ab13) As Part of a So-called Open House Model Document Type: Contract award notice Title: Conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for medicinal products with the active ingredient peginterferon beta-1a (ATC: L03AB13) as part of a so-called open-house model Reference Number: 2021 / S 023-055113 Contract Type: Supplies Estimated Value: 0.01 - EUR Description: Conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for drugs with the active ingredient peginterferon beta-1a (ATC: L03AB13) within the period from February 1, 2021 to January 31, 2023 with the possibility of concluding a contract at any time (open-house Model). 33600000 - Pharmaceutical products Authority Type: Body governed by public law Type of Procedure: Open procedure Regulation: European Union Bid Type: Not applicable Doc Title: Pharmaceutical products Dispatch Date: 2021-01-29 Publish Date: 2021-02-03 Germany Contract value : 0.01 EUR Contractors : AXICORP PHARMA GMBH, BIOGEN GMBH, ABACUS MEDICINE A / S, EURIMPHARM ARZNEIMITTEL GMBH, ORIGINALIS B.V. 08/01/2021 04/02/2021 See in details 77068226 04/02/2021 AOK - RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE COMPANY Address : Address : Virchowstra e 30 Town : Eisenberg NUTS-Code : NL - NEDERLAND Postal Code : 67304 Contact Point : Kerstin Blasius Phone : +49 6351403363 www.aok.de/rheinland-pfalz-saarland/ am_vertraege@rps.aok.de Germany Germany Contract Awards Germany 08/01/2021 See in details 0.01 EUR | |||
| NAICS | ||||
| CPVS | ||||
| UNSPSC |
-
|
|||
| Regions | ||||
| Sectors | ||||
| Contractor | ||||
| Contract Value |
0.01 EUR
|
URL | ||
| Share | ||||
Germany
| Title |
|---|
Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for Medicinal Products with the Active Ingredient Peginterferon Beta-1a (atc: L03ab13) As Part of a So-called Open House Model Germany |
| Country |
| Language |
| English |
| Organization |
| Published Date |
| 06.02.2024 |
| Awarded Date |
| 03.02.2021 |
| Overview |
| Contract Award's Details : Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for Medicinal Products with the Active Ingredient Peginterferon Beta-1a (atc: L03ab13) As Part of a So-called Open House Model AOK - RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE COMPANY Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for Medicinal Products with the Active Ingredient Peginterferon Beta-1a (atc: L03ab13) As Part of a So-called Open House Model Document Type: Contract award notice Title: Conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for medicinal products with the active ingredient peginterferon beta-1a (ATC: L03AB13) as part of a so-called open-house model Reference Number: 2021 / S 023-055113 Contract Type: Supplies Estimated Value: 0.01 - EUR Description: Conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for drugs with the active ingredient peginterferon beta-1a (ATC: L03AB13) within the period from February 1, 2021 to January 31, 2023 with the possibility of concluding a contract at any time (open-house Model). 33600000 - Pharmaceutical products Authority Type: Body governed by public law Type of Procedure: Open procedure Regulation: European Union Bid Type: Not applicable Doc Title: Pharmaceutical products Dispatch Date: 2021-01-29 Publish Date: 2021-02-03 Germany Contract value : 0.01 EUR Contractors : AXICORP PHARMA GMBH, BIOGEN GMBH, ABACUS MEDICINE A / S, EURIMPHARM ARZNEIMITTEL GMBH, ORIGINALIS B.V. 08/01/2021 04/02/2021 See in details 77068226 04/02/2021 AOK - RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE COMPANY Address : Address : Virchowstra e 30 Town : Eisenberg NUTS-Code : NL - NEDERLAND Postal Code : 67304 Contact Point : Kerstin Blasius Phone : +49 6351403363 www.aok.de/rheinland-pfalz-saarland/ am_vertraege@rps.aok.de Germany Germany Contract Awards Germany 08/01/2021 See in details 0.01 EUR |
| NAICS |
| Other Direct Insurance (except Life Justice Regulation Justice Other Justice Regulation Direct Insurance (except Life Direct Life Other Justice |
| CPVS |
| Sections Postal orders Dates |
| UNSPSC |
| - |
| Regions |
| Europe Western Europe |
| Sectors |
| Healthcare and Medicine Automobiles and Auto Parts Supply Postal and Courier Services Law and Legal Printing and Publishing Electricity Construction Energy-Power and Electrical Computer Hardwares and Consumables Steel Pharmaceuticals |
| Contractor |
| Contract Value |
|
0.01 EUR
|
| URL |
|
|
| Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Contracts